The Department of Health and Human Services is offering the NIH HEAL INITIATIVE grant to accelerate solutions to the national opioid crisis by developing therapies and technologies for improved pain management. This grant is part of the Small Business Innovation Research program, focusing on creating non-addictive medications, devices, objective pain measurement tools, and screening models to advance pain treatment. Applications must address innovative approaches to pain therapy development. Closing date: Sep 08, 2022.
Opportunity ID: 321313
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NS-20-011 |
| Funding Opportunity Title: | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 04, 2019 |
| Last Updated Date: | Oct 04, 2019 |
| Original Closing Date for Applications: | Sep 08, 2022 |
| Current Closing Date for Applications: | Sep 08, 2022 |
| Archive Date: | Oct 14, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on applications directed at improving pain treatment, including the development of new non-addictive medications and devices and objective pain measurement. In addition, NIH is interested in new screening tools and models focused specifically on pain and development of pain therapies. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-011.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 321313 Full Announcement-RFA-NS-20-011 -> RFA-NS-20-011-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260320 | Dec 08, 2019 | Jan 24, 2022 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00255639 | Dec 08, 2019 | May 24, 2020 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270963 | Dec 16, 2021 | Sep 08, 2022 | View |
Package 1
Mandatory forms
321313 RR_SF424_2_0-2.0.pdf
321313 PHS398_CoverPageSupplement_5_0-5.0.pdf
321313 RR_OtherProjectInfo_1_4-1.4.pdf
321313 PerformanceSite_2_0-2.0.pdf
321313 RR_KeyPersonExpanded_2_0-2.0.pdf
321313 RR_Budget_1_4-1.4.pdf
321313 PHS398_ResearchPlan_4_0-4.0.pdf
321313 SBIR_STTR_Information_1_3-1.3.pdf
321313 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
321313 RR_SubawardBudget30_1_4-1.4.pdf
321313 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
321313 RR_SF424_2_0-2.0.pdf
321313 PHS398_CoverPageSupplement_4_0-4.0.pdf
321313 RR_OtherProjectInfo_1_4-1.4.pdf
321313 PerformanceSite_2_0-2.0.pdf
321313 RR_KeyPersonExpanded_2_0-2.0.pdf
321313 RR_Budget_1_4-1.4.pdf
321313 PHS398_ResearchPlan_4_0-4.0.pdf
321313 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
321313 RR_SubawardBudget30_1_4-1.4.pdf
321313 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
321313 RR_SF424_5_0-5.0.pdf
321313 PHS398_CoverPageSupplement_5_0-5.0.pdf
321313 RR_OtherProjectInfo_1_4-1.4.pdf
321313 PerformanceSite_4_0-4.0.pdf
321313 RR_KeyPersonExpanded_4_0-4.0.pdf
321313 RR_Budget_3_0-3.0.pdf
321313 PHS398_ResearchPlan_4_0-4.0.pdf
321313 SBIR_STTR_Information_3_0-3.0.pdf
321313 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
321313 RR_SubawardBudget30_3_0-3.0.pdf
321313 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
